Christoph Wagener

from Wikipedia, the free encyclopedia

Christoph Wagener (born October 4, 1947 in Eckenhagen ) is a German laboratory physician specializing in oncology .

Life

Christoph Wagener studied medicine at the Rheinische Friedrich-Wilhelms University in Bonn and in 1974 with the work of pulmonary tuberculosis in untreated first admissions from 1946 to 1970 The change of the clinical doctorate ( retrospective medical record analysis ). In 1980 he completed his habilitation with the topic of localization and concentration of the carcinoembryonic antigen (CEA) in tissue, tumor spread and tumor histology ( immunohistochemical analysis ). In 1988 he was appointed C4 professor at the University of Hamburg . In 2013 he was retired.

From 1989 to 2013, Wagener was director of the Institute for Clinical Chemistry at the University Medical Center Hamburg-Eppendorf . He dealt in particular with genetic diagnostics and developed new methods for the early diagnosis of micrometastases in a tumor recurrence or for the early detection of rejection reactions after an organ transplant as well as possibilities for improvement through genetic diagnostics for the classification of certain cancers .

In February 2000, he served as director of the institute participated in the demonstration that the protein CEACAM1 (carcinoembryonic antigen related cell adhesion molecule ; carcinoembryonic antigen-related cell adhesion molecule; CD66a) new blood vessels can grow. The protein CEACAM1 is also a focus of his research.

From 2001 to 2003, Wagener was dean of the medical faculty at the University of Hamburg. From 2005 to 2007 he was Medical Director of the Center for Clinical Pathology and from 2007 to 2009 Deputy Medical Director of the Diagnostic Center. He was on the advisory board of the Hamburg University Society .

Fonts (selection)

  • The change in the clinical picture of pulmonary tuberculosis in untreated initial admissions between 1946 and 1970. 1974. (Dissertation, University of Bonn, Medical Faculty, 1974)
  • Localization and Concentration of Carcinoembryonic Antigen (CEA) in Tissue, Tumor Spread, and Tumor Histology: A Contribution to Understanding Elevated CEA Plasma Concentrations in Carcinomas of the Gastrointestinal Tract. 1980. (Habilitation thesis, University of Bonn, Medical Faculty, 1980)
  • with Siegfried Neumann (Ed.): Molecular diagnostics of cancer. Springer, Berlin 1993, ISBN 3-540-55476-9 , doi: 10.1007 / 978-3-642-77521-5 .
  • Introduction to molecular oncology: changes and effects of tumor genes and tumor proteins. Thieme, Stuttgart 1996, ISBN 3-13-103511-0 .

Web links

Individual evidence

  1. a b Kürschner's German Scholars Calendar . 18th edition. Volume 3, 2001, p. 3405.
  2. a b c Prof. Dr. Dr. Thomas Renné new director of the Institute for Clinical Chemistry. ( Memento of the original from November 3, 2013 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. Press release of the University Medical Center Hamburg-Eppendorf, July 11, 2013, accessed on October 31, 2013.  @1@ 2Template: Webachiv / IABot / www.uke.de
  3. ^ S. Ergun, N. Kilik, G. Ziegeler, A. Hansen, P. Nollau, J. Gotze, JH Wurmbach, A. Horst, J. Weil, M. Fernando, C. Wagener: CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. In: Mol Cell. 5 (2), Feb 2000, pp. 311-320. PMID 10882072